Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank
Abstract Background Evidence suggests there may be a bidirectional relationship between high blood pressure (BP) and Alzheimer’s disease (AD). It is hypothesised that this is due to cerebral changes during pre-clinical AD that cause elevation of systemic BP. We aimed to test this by exploring the ef...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | BMC Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12916-025-04295-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849226201765249024 |
|---|---|
| author | Jennifer C. Palmer Emma Hart Emma Anderson Seth Love Deborah A. Lawlor |
| author_facet | Jennifer C. Palmer Emma Hart Emma Anderson Seth Love Deborah A. Lawlor |
| author_sort | Jennifer C. Palmer |
| collection | DOAJ |
| description | Abstract Background Evidence suggests there may be a bidirectional relationship between high blood pressure (BP) and Alzheimer’s disease (AD). It is hypothesised that this is due to cerebral changes during pre-clinical AD that cause elevation of systemic BP. We aimed to test this by exploring the effect of risk of pre-clinical AD on blood pressure. Methods We used data from the UK Biobank, including adults without prevalent or incident (within first 5 years of follow-up) clinical AD (N = 501,420, mean age 56.6, SD 8 years). We used two instrumental variables, an age-weighted parental dementia instrument score and a participant genetic instrument score, that are vulnerable to differing biases, to instrument risk of pre-clinical AD (the exposure). We tested the association of both instrument scores with systolic BP (SBP), diastolic BP (DBP), and hypertension. Sensitivity analyses were undertaken to explore different biases. Results Both the higher parental dementia instrument and participant genetic instrument score were associated with higher mean SBP (difference in mean SBP mmHg per 1SD higher score: 0.12, 95% CI 0.06 to 0.17, p < 0.0001, and 0.07, 95% CI 0.00 to 0.13, p=0.037, respectively) but not DBP. Sensitivity analyses were largely consistent with these findings. Conclusions Our findings provide preliminary evidence that pre-clinical AD increases SBP. Further research is required to determine whether this increase in SBP is due to increased cerebrovascular resistance as a result of pre-clinical AD. Obtaining a better understanding of the changing relationship with BP at different stages of AD may enable effective optimisation and targeting of therapies. |
| format | Article |
| id | doaj-art-49e29db0e5434c98aedd415bcfa3da40 |
| institution | Kabale University |
| issn | 1741-7015 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Medicine |
| spelling | doaj-art-49e29db0e5434c98aedd415bcfa3da402025-08-24T11:33:54ZengBMCBMC Medicine1741-70152025-08-0123111510.1186/s12916-025-04295-5Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK BiobankJennifer C. Palmer0Emma Hart1Emma Anderson2Seth Love3Deborah A. Lawlor4Bristol Medical School, Population Health Sciences, University of BristolSchool of Physiology, Pharmacology and Neuroscience, University of BristolBristol Medical School, Population Health Sciences, University of BristolDementia Research Group, Institute of Clinical Neurosciences, Bristol Medical School, University of BristolBristol Medical School, Population Health Sciences, University of BristolAbstract Background Evidence suggests there may be a bidirectional relationship between high blood pressure (BP) and Alzheimer’s disease (AD). It is hypothesised that this is due to cerebral changes during pre-clinical AD that cause elevation of systemic BP. We aimed to test this by exploring the effect of risk of pre-clinical AD on blood pressure. Methods We used data from the UK Biobank, including adults without prevalent or incident (within first 5 years of follow-up) clinical AD (N = 501,420, mean age 56.6, SD 8 years). We used two instrumental variables, an age-weighted parental dementia instrument score and a participant genetic instrument score, that are vulnerable to differing biases, to instrument risk of pre-clinical AD (the exposure). We tested the association of both instrument scores with systolic BP (SBP), diastolic BP (DBP), and hypertension. Sensitivity analyses were undertaken to explore different biases. Results Both the higher parental dementia instrument and participant genetic instrument score were associated with higher mean SBP (difference in mean SBP mmHg per 1SD higher score: 0.12, 95% CI 0.06 to 0.17, p < 0.0001, and 0.07, 95% CI 0.00 to 0.13, p=0.037, respectively) but not DBP. Sensitivity analyses were largely consistent with these findings. Conclusions Our findings provide preliminary evidence that pre-clinical AD increases SBP. Further research is required to determine whether this increase in SBP is due to increased cerebrovascular resistance as a result of pre-clinical AD. Obtaining a better understanding of the changing relationship with BP at different stages of AD may enable effective optimisation and targeting of therapies.https://doi.org/10.1186/s12916-025-04295-5Blood pressurePre-clinical Alzheimer’s diseaseProspective cohortInstrumental variablesHuman population |
| spellingShingle | Jennifer C. Palmer Emma Hart Emma Anderson Seth Love Deborah A. Lawlor Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank BMC Medicine Blood pressure Pre-clinical Alzheimer’s disease Prospective cohort Instrumental variables Human population |
| title | Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank |
| title_full | Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank |
| title_fullStr | Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank |
| title_full_unstemmed | Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank |
| title_short | Exploring the effect of pre-clinical Alzheimer’s disease on blood pressure using Mendelian randomisation and parental dementia as an instrumental variable in UK Biobank |
| title_sort | exploring the effect of pre clinical alzheimer s disease on blood pressure using mendelian randomisation and parental dementia as an instrumental variable in uk biobank |
| topic | Blood pressure Pre-clinical Alzheimer’s disease Prospective cohort Instrumental variables Human population |
| url | https://doi.org/10.1186/s12916-025-04295-5 |
| work_keys_str_mv | AT jennifercpalmer exploringtheeffectofpreclinicalalzheimersdiseaseonbloodpressureusingmendelianrandomisationandparentaldementiaasaninstrumentalvariableinukbiobank AT emmahart exploringtheeffectofpreclinicalalzheimersdiseaseonbloodpressureusingmendelianrandomisationandparentaldementiaasaninstrumentalvariableinukbiobank AT emmaanderson exploringtheeffectofpreclinicalalzheimersdiseaseonbloodpressureusingmendelianrandomisationandparentaldementiaasaninstrumentalvariableinukbiobank AT sethlove exploringtheeffectofpreclinicalalzheimersdiseaseonbloodpressureusingmendelianrandomisationandparentaldementiaasaninstrumentalvariableinukbiobank AT deborahalawlor exploringtheeffectofpreclinicalalzheimersdiseaseonbloodpressureusingmendelianrandomisationandparentaldementiaasaninstrumentalvariableinukbiobank |